Medicenna Therapeutics Corp. (MDNAF)
OTCMKTS
· Delayed Price · Currency is USD
0.7870
-0.0800 (-9.23%)
May 2, 2025, 4:00 PM EDT
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of $59.52 million as of May 2, 2025. Its market cap has decreased by -29.63% in one year.
Market Cap
59.52M
Enterprise Value
37.91M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.79
Market Cap Chart
Since March 8, 2017, Medicenna Therapeutics's market cap has increased from 48.70M to 59.52M, an increase of 22.21%. That is a compound annual growth rate of 2.49%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.62B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 746.57M |
| Tian'an Technology Group | 546.22M |
| Glass House Brands | 529.49M |
| Elite Pharmaceuticals | 452.95M |
| Northwest Biotherapeutics | 429.16M |
| CytoDyn | 401.57M |